Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3679-3693
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3679
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3679
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Freedman et al[20], 2000 | 1994-1997 | Case-control | 189 | 820 | Self report | Pathology records | - | RR = 1.03 (0.63-1.69) | Age, gender, alcohol, smoking, BMI, physical activity, education, diet | 37 |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 132/5488 | 2572/1000000 | Medicare database | Cancer registry | > 6 | OR = 0.95 (0.80-1.14) | Age, gender, diabetes | 49 |
Freedman et al[23], 2001 | 1965-1997 | Cohort | 53/268312 | National registry | Cancer registry | > 10 | SIR = 1.3 (1.0-1.8) | Age, gender | 38 | |
Goldacre et al[22], 2005 | 1963-1999 | Cohort | 91/39245 | 803/334813 | NHS database | Cancer registry | NA | RR = 0.98 (0.79-1.21) | Age, gender, calendar year, residence | 36 |
Lagergren and Mattsson[24], 2011 | 1965-2008 | Cohort | 126 | 345251 | NA | Cancer registry | 15 | RR = 1.29 (1.07-1.53) | Age, gender, calendar Year | 40 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Freedman et al[20], 2000 | 1994-1997 | Case-control | 167 | 820 | Self-report | Pathology records | OR = 0.82 (0.43-1.54) | Age, gender, alcohol, smoking, BMI, physical activity, education, diet | 37 | |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 100/4732 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 0.85 (0.69-1.04) | Age, gender, diabetes | 49 |
Ichimiya et al[26], 1986 | 1953-1984 | Cohort | 29 | 1238 | Self report | Death registry | < 31 | 0.59 (0.26-1.36 | Age, gender | 48 |
Freedman et al[23], 2001 | 1965-1997 | Cohort | 129/268312 | NA | National registry | Cancer registry | > 10 | SIR = 0.9 (0.7-1.1) | Age, gender | 38 |
Lagergren and Mattsson[24], 2011 | 1965-2008 | Cohort | 193/345251 | NA | Cancer registry | 15 | SIR 0.93 (0.81-1.08) | Age, gender, calendar year | 40 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Freedman et al[20], 2000 | 1994-1997 | Case-control | 262 | 820 | Self-report | Pathology | - | RR = 0.67 (0.39-1.13) | Age, gender, alcohol, smoking, BMI, physical activity, education, diet | 37 |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 122/5579 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 0.88 (0.73-1.06) | Age, gender, diabetes | 49 |
Fall et al[28], 2007 | 1970-1997 | Cohort | 94/251672 | NA | National registry | Cancer registry | 11.5 | RR = 0.95 (0.76-1.16) | Age, gender, surgical procedure | 42 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Sarli et al[27], 1986 | 1980-1984 | Case control | 157 | 157 | Surgical and database | Pathology | NA | 0.77 (0.09-6.40) | Age, gender | 26 |
Ichimiya et al[26], 1986 | 1953-1984 | Cohort | 29 | 1238 | Self report | Death registry | NA | 0.92 (0.66-1.28) | Age, gender | 33 |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 429/12925 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.26 (1.13-1.40) | Age, gender, diabetes | 49 |
Goldacre et al[22], 2005 | 1963-1999 | Cohort | 177/39254 | 1354/334813 | NHS database | Cancer registry | NA | 1.06 (0.88-1.26) | Age, gender, calendar year, residence | 36 |
Fall et al[28], 2007 | 1970-1997 | Cohort | 854/251672 | NA | National registry | Cancer registry | 11.5 | 1.11 (1.04-1.19) | Age, gender, surgical procedure | 42 |
Chen et al[29], 2014 | 2000-2010 | Cohort | 31/5850 | National database | Cancer registry | 10 | 1.81 (1.09-3.02) | Age, gender, comorbidities | 53 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Wynder et al[37], 1973 | 1950-1964 | Case-control | 11/142 | 16/307 | Hospital records | NA | > 2 | 1.57 (0.76-3.24)1 | Age, gender, race, hospital | 28 |
Haines et al[38], 1982 | 1973-1978 | Case-control | 8/116 | 18/232 | Hospital records | Medical records | ≥ 5 | 0.89 (0.40-1.98)1 | Age, gender, race, year of admission | 27 |
Mack et al[39], 1986 | 1976-1981 | Case-control | 38/490 | 44/490 | Hospital records | Pathology records | > 1 | 0.8 (0.5-1.4) | Age, gender, race | 27 |
Cuzick and Babiker[40] 1989 | 1983-1986 | Case-control | 14/216 | 7/279 | Hospital records | Medical records | NA | 2.43 (0.91-7.12 | Age, gender | 29 |
Farrow and Davis[41] 1990 | 1982-1986 | Case-control | 8/218 | 6/188 | Hospital records | Cancer registry | ≥ 3 | 1.1 (0.3-3.4) | Age | 29 |
Bueno de Mesquite et al[42], 1992 | 1984-1988 | Case-control | 24/176 | 44/487 | Hospital records | Medical records | > 5 | 1.15 (0.55-2.40) | Age, response status, smoking | 31 |
Lee et al[43], 1996 | 1989-1994 | Case-control | 12/282 | 6/282 | Hospital records | Medical records | NA | 2.04 (0.76-6.21) | Age, gender | 43 |
Gullo et al[45], 1996 | 1987-1992 | Case-Control | 93/720 | 71/720 | Hospital records | Medical records | > 1 | 1.00 (0.70-1.43) | Age, gender | 34 |
Silverman et al[30], 2001 | 1986-1989 | Case-Control | 132/484 | 150/2099 | Hospital records | Pathology records | > 2 | 1.77 (1.26-2.48)1 | Age, race, gender, smoking, alcohol consumption, BMI, Calorie intake. | 31 |
Ko et al[32], 2007 | 1995-1999 | Case-control | 75/532 | 155/1701 | Hospital records | SEER abstracts | NA | 1.73 (1.29-2.33)1 | Ag, gender, BMI, smoking, diabetes | 36 |
Hassan et al[44], 2007 | 2000-2006 | Case-Control | 808 | 808 | Hospital records | Self reported | > 2 | OR = 1.1 (0.9-1.8) | Age, gender, smoking, comorbidities | 35 |
Zhang et al[31], 2014 | 1994-1998 | Case-Control | 215 | 676 | Self report | Pathology reports | > 2 | 2.11 (1.32-3.35) | Age, gender, race, smoking, physical activity, diabetes | 51 |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 1106/33280 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.23 (1.15-1.33) | Age, gender, diabetes | 49 |
Ichimiya et al[26], 1986 | 1953-1984 | Cohort | 3/1238 | NA | National registry | Death registry | NA | SMR = 0.86 (0.33-2.25)1 | Age, gender | 33 |
Shibata et al[46], 1994 | 1981-1990 | Cohort | 65/13979 | NA | Hospital records | NA | > 4 | RR = 2.09 (0.99-4.39) | Age, gender, smoking | 32 |
Ekbom et al[33], 1996 | 1965-1987 | Cohort | 261/62615 | NA | National registry | Cancer registry | > 1 | 1.20 (1.06-1.36) | Age, gender | 28 |
Chow et al[34], 1999 | 1977-1993 | Cohort | 184/42461 | NA | National registry | Cancer registry | ≥ 4 | 1.3 (1.1-1.6) | Age, gender, obesity, years of follow-up, other comorbidities | 33 |
Coughlin et al[35], 2000 | 1982-1996 | Cohort | 3751/1.2 M | NA | Study database | Cancer registry | 14 | RR = 1.2 (1.0-1.5) | Age, gender, smoking, race, education, BMI, diet. | 31 |
Ye et al[48], 2001 | 1965-1997 | Cohort | 730/268312 | NA | National database | Cancer registry | ≥ 2 | SIR = 1.06 (0.98-1.14) | Age, gender, calendar year | 35 |
Schernhammer et al[47], 2002 | 1976-1986 | Cohort | 37/145927 | 256/1675355 | Self-report | Self report and death registry | > 10 | 1.23 (0.86-1.77) | Age, gender, BMI, Physical activity, diabetes | 34 |
Goldacre et al[22], 2005 | 1963-1999 | Cohort | 127/39254 | 791/334813 | NHS database | Cancer registry | ≥ 2 | 1.06 (0.88-1.26) | Age, gender, calendar year, residence. | 36 |
Arnold et al[36], 2009 | 1984-2004 | Cohort | 6243/1060389 | NA | Hospital records | Death registry | NA | HR = 1.62 (1.02-2.55) blackHR = 1.10 (1.0-1.22) white | Age, gender, BMI, smoking, FH of pancreatic cancer, diabetes. | 41 |
Chen et al[29], 2014 | 2000-2010 | Cohort | 16/5850 | National database | Cancer registry | 10 | 1.13 (0.60-2.12) | Age, gender, comorbidities | 53 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 118/3681 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.19 (0.98-1.43) | Age, gender, diabetes | 49 |
Chow et al[34], 1999 | 1977-1993 | Cohort | 16/42461 | NA | National registry | Cancer registry | ≥ 4 | 0.7 (0.3-1.4) | Age, gender, obesity, years of follow-up, other comorbidities | 33 |
Chen et al[29], 2014 | 2000-2010 | Cohort | 9/5850 | National database | Cancer registry | 10 | 2.22 (0.91-5.41) | Age, gender, comorbidities | 53 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 332/10219 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.23 (1.15-1.33) | Age, gender, diabetes | 49 |
Chow et al[34], 1999 | 1977-1993 | Cohort | 48/42461 | NA | National registry | Cancer registry | ≥ 4 | 1.1 (0.7-1.5) | Age, gender, obesity, years of follow-up, other comorbidities | 33 |
Goldacre et al[22], 2005 | 1963-1999 | Cohort | 38/39245 | 306/334813 | NHS database | Cancer registry | NA | 0.91 (0.64-1.25) | Age, gender, calendar year, residence | 36 |
Chen et al[29], 2014 | 2000-2010 | Cohort | 87/5850 | 163/5850 | National database | Cancer registry | 10 | 1.17 (0.90-1.52) | Age, gender, comorbidities | 53 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 148/3694 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.49 (1.26-1.77) | Age, gender | 49 |
Lagergren et al[51], 2001 | 1965-1997 | Cohort | 68/2784601 | NA | National registry | National registry | 10 | 1.77 (1.37-2.24) | Age, gender, time aftercholecystectomy | 38 |
Lagergren et al[51], 2001 | 1965-1997 | Cohort | 98/2784602 | NA | National registry | National registry | 10 | 1.71 (1.39-2.08) | Age, gender, time aftercholecystectomy | 38 |
Goldacre et al[52], 2012 | 1998-2008 | Cohort | NA | 327460/3M | HES database | Cancer registry | 10 | 2.47 (0.82-6.28) | Age, gender, period since cholecystectomy | 45 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 3907/150045 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 0.97 (0.92-1.02) | Age, gender | 49 |
Schmidt et al[60], 2012 | 1992 -1994 | Case-Control | 10/254 | 0/1043 | National database | Cancer registry | 24 | HR = 1.20 (0.85-1.70) | Age, gender | 41 |
Todoroki et al[67], 1999 | 1991-1994 | Case-Control | 226/1982 | 270/2129 | Medicare database and self report | Cancer registry | ≥ 2 | OR = 1.1 (0.9-1.3) | Age, gender, Family history, BMI, diet, NSAIDs | 48 |
Zeng et al[62], 1993 | 1965-1986 | Case-Control | 8/503 | 18/2188 | Hospital records | Hospital records | ≥ 2.5 | OR = 1.95 (0.84-4.51) | 26 | |
Neugut et al[66], 1991 | 1986-1988 | Case-Control | 11/106 | 41/507 | Hospital Records | Self-report | 2 | OR = 0.96 (0.46-1.98) | Age, gender | 34 |
Lee et al[54], 1989 | 1980-1987 | Case-Control | 40/165 | 19/165 | Hospital Records | Hospital Records | ≥ 2 | RR = 2.11 (1.19-3.85) | 30 | |
Kune et al[65], 1988 | 1980-1981 | Case-Control | 35/715 | 57/727 | Hospital Records | Self-reporting and hospital records | RR = 1.10 (0.7-1.1) | 36 | ||
Neugut et al[58], 1988 | 1983-1985 | Case-Control | 11/56 | 10/84 | Hospital records | Self-reporting | OR = 1.8 (0.6-5.4) | Age, socioeconomic status | 38 | |
Friedman et al[63], 1987 | 1971-1984 | Case-Control | 174/5898 | 773/27687 | Medicare Database | Cancer registry | ≥ 2 | OR = 1.1 (0.9-1.2) | Age, gender, geographical area, calendar year | 47 |
1Weiss et al[53], 1982 | 1976-1977 | Case-Control | 92 | 687 | Cancer Registry | Self-reporting | ≥ 1 | RR = 1.4 (0.7-2.6) | 40 | |
2Turnbull et al[61], 1981 | 1972-1976 | Case-Control | 20/305 | 5 | Hospital records | Hospital records | > 5 | RR = 2.7 | 33 | |
Chen et al[29], 2014 | 2000-2010 | Cohort | 67/5850 | 76/5850 | National database | Cancer registry | 10 | HR = 1.56 (1.12-2.17) | Age, gender, comorbidities | 53 |
2Hartz et al[55], 2012 | 1993-1998 | Cohort | 1207/150912 | NA | National database | Self-report | 8 | HR = 1.36 (1.13-1.64) | Age, smoking, obesity, Family history, comorbidities | 48 |
Shao et al[56], 2005 | 1987-2002 | Cohort | 297/55960 | 574668 | National database | National database | IRR = 1.32 (1.16-1.48 | Age, gender | 54 | |
2Schernhammer et al[59], 2003 | 1982-1998 | Cohort | 133/6669 | 78515 | National database of nurses | Self-report and National death registry | 16 | RR = 1.21 (1.01-1.46) | Age, smoking, BMI, lifestyle factors, comorbidities | 57 |
1Johansen et al[64], 1996 | 1977-1989 | Cohort | 225/42098 | NA | Hospital database | Cancer registry | 1-16 | RR = 1.09 (1.0-1.2) | Age, gender, calendar year | 43 |
Linos et al[57], 1981 | 1950-1969 | Cohort | 42/1681 | Hospital database | Hospital records and self reporting | 2RR = 1.3 (0.9-1.9)3RR = 1.3 (0.7-2.2) | 34 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 1963/66740 | 2,572/100000 | Medicare database | Cancer registry | > 6 | OR = 1.06 (0.99-1.12) | Age, gender | 49 |
Todoroki et al[67], 1999 | 1991-1994 | Case-control | 134/967 | 270/2129 | Medicare database and self report | Cancer registry | ≥ 2 | OR = 1.3 (1.0-1.6) | Age, gender, family history, BMI, diet, NSAID use | 48 |
Zeng et al[62], 1993 | 1965-1986 | Case-control | 5/108 | 18/2188 | Hospital records | Hospital records | ≥ 2.5 | OR = 5.85 (2.13-16.7) | 26 | |
Friedman et al[63], 1987 | 1971-1984 | Case-control | 70/1925 | 773/27687 | Medicare Database | Cancer registry | ≥ 2 | OR = 1.2 (0.9-1.5) | Age, gender, geographical area, calendar year | 47 |
Vernick et al[69], 1981 | 1975-1978 | Case-control | 21/150 | 23/250 | National database | Self-report and hospital records | RR = 1.77 (0.95-3.3) | 44 | ||
1Schernhammer et al[59], 2003 | 1982-1998 | Cohort | 46/6669 | 78515 | National database of nurses | Self-report and National death registry | 16 | RR = 1.35 (0.97-1.88) | Age, smoking, BMI, lifestyle factors, comorbidities | 57 |
Lagergren et al[51], 2001 | 1965-1997 | Cohort | 861/278460 | NA | National registry | National registry | 10 | SIR = 1.16 (1.08-1.24) | Age, gender, time after cholecystectomy | 35 |
1Ekbom et al[68], 1993 | 1965-1983 | Cohort | 633/62615 | National registry | National registry | < 23 | SIR = 1.24 (1.03-1.48) | Age | 46 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Nogueira et al[21], 2014 | 1992-2005 | Case-control | 986/40996 | 2572/100000 | Medicare database | Cancer registry | > 6 | OR = 0.93 (0.86-1.00) | Age, gender | 49 |
Todoroki et al[67], 1999 | 1991-1994 | Case-Control | 87/965 | 270/2129 | Medicare database and self report | Cancer registry | ≥ 2 | OR = 0.8 (0.6-1.1) | Age, gender, Family history, BMI, diet, NSAID use | 48 |
Zeng et al[62], 1993 | 1965-1986 | Case-Control | 2/131 | 18/2188 | Hospital records | Hospital records | ≥ 2.5 | OR = 1.87 (0.43-8.14) | 26 | |
Friedman et al[63], 1987 | 1971-1984 | Case-Control | 60/1963 | 773/27687 | Medicare database | Cancer registry | ≥ 2 | OR = 1.2 (0.9-1.6) | Age, gender, geographical area, calendar year | 47 |
Schernhammer et al[59], 2003 | 1982-1998 | Cohort | 28/6669 | 78515 | National database of nurses | Self-report and National death registry | 16 | RR = 0.95 (0.64-1.43) | Age, smoking, BMI, lifestyle factors, comorbidities | 57 |
Lagergren et al[51], 2001 | 1965-1997 | Cohort | 2564/278460 | NA | National registry | National registry | 10 | SIR = 0.98 (0.94-1.02) | Age, gender, time after cholecystectomy | 35 |
Ref. | Period of study | Study design | No. of cases | No. of controls | Exposure ascertainment | Outcome ascertainment | Follow-up (yr) | Effect estimate | Adjustments | Quality of publication |
Chiong et al[70], 2012 | 1950-2012 | Meta-Analysis | 14226/460262 | NA | Mixed sources | Mixed sources | Variable | OR = 1.14 (0.92-1.41) | Age, gender | 54 |
Zeng et al[62], 1993 | 1965-1986 | Case-Control | 1/264 | 18/2188 | Hospital records | Hospital records | ≥ 2.5 | OR = 0.46 (0.06-3.45) | 26 | |
Kune et al[65], 1988 | 1980-1981 | Case-Control | 29/715 | 57/727 | Hospital records | Self-reporting and hospital records | RR = 1.22 (0.7-2.0) | 36 | ||
Friedman et al[63], 1987 | 1971-1984 | Case-Control | 43/1921 | 773/27687 | Medicare database | Cancer registry | ≥ 2 | OR = 0.9 (0.6-1.2) | Age, gender, geographical area, calendar year | 47 |
Weiss et al[53], 1982 | 1976-1977 | Case-Control | 49 | 687 | Cancer registry | Self-reporting | ≥ 1 | RR = 1.0 (0.4-2.4) | Age | 40 |
Shao et al[56], 2005 | 1987-2002 | Cohort | 83/55960 | 574668 | National database | National database | IRR = 1.00 (0.85-1.17) | Age, gender | 54 | |
1Schernhammer et al[59], 2003 | 1982-1998 | Cohort | 32/6669 | 78515 | National database of nurses | Self-report and National death registry | 16 | RR = 1.58 (1.05-2.36) | Age, smoking, BMI, lifestyle factors, comorbidities | 57 |
2Johansen et al[64], 1996 | 1977-1989 | Cohort | 119/42098 | NA | Hospital register | Cancer registry | 1-16 | RR = 1.07 (0.9-1.3) | Age, gender, calendar year | 43 |
Linos et al[57], 1981 | 1950-1969 | Cohort | 17/168134/1681 | Hospital database | Hospital records and self reporting | 1RR = 0.5 (0.1-1.3)3RR = 2.3 (0.9-4.8) | 34 |
- Citation: Coats M, Shimi SM. Cholecystectomy and the risk of alimentary tract cancers: A systematic review. World J Gastroenterol 2015; 21(12): 3679-3693
- URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3679.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i12.3679